CHSA0108
Resource Report
Resource Website
|
RRID:CVCL_X484
|
Homo sapiens (Human)
|
Chondrosarcoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:27397505 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
CHSA 0108 |
|
|
ArrayExpress:E-MTAB-3610, cancercelllines:CVCL_X484, Cell_Model_Passport:SIDM00050, Cosmic-CLP:1290768, DepMap:ACH-002093, EGA:EGAS00001000978, GDSC:1290768, PharmacoDB:CHSA0108_202_2019, PRIDE:PXD030304, Wikidata:Q54813311 |
|
|
CVCL_X484 |
2026-08-15 04:20:52 |
0 |
CL-14
Resource Report
Resource Website
|
RRID:CVCL_1979
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474)., Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:15316659 PMID:19003396 PMID:22460905 PMID:25926053 PMID:26589293 PMID:28196595 PMID:30894373 PMID:31068700 PMID:34339474
|
Cancer cell line
|
Male |
CL14 |
|
|
ArrayExpress:E-MTAB-2770, BioSample:SAMN03473569, BioSample:SAMN10988457, cancercelllines:CVCL_1979, Cell_Model_Passport:SIDM01491, ColonAtlas:CL14, DepMap:ACH-000342, DSMZ:ACC-504, DSMZCellDive:ACC-504, GEO:GSM513932, GEO:GSM514184, GEO:GSM886934, GEO:GSM888000, GEO:GSM1448171, IARC_TP53:28287, LiGeA:CCLE_737, PharmacoDB:CL14_207_2019, Progenetix:CVCL_1979, Wikidata:Q54813473 |
|
|
CVCL_1979 |
2026-08-15 04:20:56 |
0 |
C2BBe1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1096
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1506435 PMID:15868485 PMID:20164919 PMID:20570890 PMID:20606684 PMID:22460905 PMID:25388687 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28854368 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
C2BBE1, C2BBe 1, Caco-2/BBe 1, Caco-2/BBe, Caco-2BBe, Caco-2BBE, Caco-2 BBe, Caco2-BBE, Caco2BBe, Caco2BBE, CACO2BBE, BBE, Caco-2 Brush Border expressing 1 |
|
|
BTO:BTO_0005156, CLO:CLO_0002108, EFO:EFO_0006546, MCCL:MCC:0000089, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2102, BCRC:60182, BCRJ:0270, BioGRID_ORCS_Cell_line:580, BioSample:SAMN03472296, BioSample:SAMN10987952, cancercelllines:CVCL_1096, Cell_Model_Passport:SIDM01233, ChEMBL-Cells:CHEMBL3308231, ChEMBL-Targets:CHEMBL2366283, ColonAtlas:C2BBE1, Cosmic:687516, Cosmic:910700, Cosmic:1479619, Cosmic-CLP:910700, DepMap:ACH-000009, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910700, GEO:GSM886897, GEO:GSM887962, GEO:GSM1669635, IARC_TP53:21203, LiGeA:CCLE_083, LINCS_LDP:LCL-1296, PharmacoDB:C2BBe1_153_2019, PRIDE:PXD005235, PRIDE:PXD030304, Progenetix:CVCL_1096, PubChem_Cell_line:CVCL_1096, Sigma-Aldrich:MTOX1000CC, Wikidata:Q54808117 |
cvcl_0025 |
|
CVCL_1096 |
2026-08-15 04:19:52 |
20 |
CADO-ES1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1103
|
Homo sapiens (Human)
|
Ewing sarcoma
|
Caution: Was incorrectly indicated to have an EWSR1-FLI1 (EWS-FLI1) gene fusion in PubMed=23637631., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1756482 PMID:11668190 PMID:19787792 PMID:20164919 PMID:21822310 PMID:22142829 PMID:22460905 PMID:23637631 PMID:25984343 PMID:26428435 PMID:26589293 PMID:27397505 PMID:29464090 PMID:30563222 PMID:30879952 PMID:30894373 PMID:31068700 PMID:33460449 PMID:35839778
|
Cancer cell line
|
Female |
CADO-ES-1, Cado-ES-1, CADO ES1, CADOES1, CADO-ES, Cado-ES, ESCADO1, Center for Adult Diseases Osaka-Ewing Sarcoma 1 |
|
|
CLO:CLO_0002173, EFO:EFO_0002818, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-6067, ArrayExpress:E-MTAB-6111, BioGRID_ORCS_Cell_line:164, BioSample:SAMN03473333, BioSample:SAMN10988559, cancercelllines:CVCL_1103, Cell_Model_Passport:SIDM00961, CLS:300127, Cosmic:753539, Cosmic:1718434, Cosmic:2294581, Cosmic-CLP:753539, DepMap:ACH-000210, DSMZ:ACC-255, DSMZCellDive:ACC-255, EGA:EGAS00001000978, GDSC:753539, GEO:GSM510004, GEO:GSM886901, GEO:GSM887966, GEO:GSM1669643, IARC_TP53:21207, LiGeA:CCLE_114, PharmacoDB:CADOES1_162_2019, PRIDE:PXD030304, Progenetix:CVCL_1103, Wikidata:Q54808333 |
|
|
CVCL_1103 |
2026-08-15 04:19:54 |
3 |
Caco-2
Resource Report
Resource Website
5000+ mentions
|
RRID:CVCL_0025
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257; PubMed=34339474)., Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659; PubMed=15731278)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:327080 PMID:833871 PMID:2914637 PMID:3349466 PMID:3518877 PMID:6935474 PMID:7459858 PMID:7764660 PMID:8253353 PMID:8508948 PMID:9294210 PMID:10092214 PMID:10612807 PMID:10737795 PMID:11414198 PMID:11416159 PMID:11668190 PMID:12584437 PMID:14599474 PMID:15316659 PMID:15731278 PMID:15868485 PMID:16418264 PMID:16854228 PMID:16957166 PMID:18258742 PMID:20570890 PMID:20606684 PMID:20831567 PMID:21607810 PMID:23272949 PMID:23932154 PMID:24042735 PMID:24755471 PMID:25485619 PMID:25841592 PMID:25877200 PMID:25926053 PMID:25944804 PMID:25960936 PMID:26537799 PMID:26589293 PMID:26869432 PMID:28196595 PMID:28683746 PMID:29101300 PMID:29787057 PMID:30894373 PMID:31068700 PMID:31981602 PMID:33389257 PMID:34339474
|
Cancer cell line
|
Male |
CaCo-2, CACO-2, Caco 2, CACO 2, CACO2, CaCo2, CaCO2, Caco2, Caco-2/ATCC, Caco-II |
|
|
BTO:BTO_0000195, CLO:CLO_0002172, CLO:CLO_0050627, EFO:EFO_0001099, MCCL:MCC:0000120, CLDB:cl614, CLDB:cl615, CLDB:cl616, CLDB:cl617, CLDB:cl618, CLDB:cl619, CLDB:cl621, CLDB:cl5174, Abcam:ab275464, AddexBio:C0009009/29, ArrayExpress:E-MTAB-2706, ATCC:HTB-37, BCRJ:0059, BioSample:SAMN03473140, BioSample:SAMN05292461, BioSample:SAMN10989600, cancercelllines:CVCL_0025, CCRID:1101HUM-PUMC000100, CCRID:1102HUM-NIFDC00087, CCRID:3101HUMSCSP5027, CCRID:3101HUMTCHu146, CCRID:4201HUM-CCTCC00153, CCRID:5301HUM-KCB07010YJ, CCTCC:GDC0153, Cell_Model_Passport:SIDM00891, ChEMBL-Cells:CHEMBL3307519, ChEMBL-Targets:CHEMBL614058, CLS:300137, ColonAtlas:CACO2, Cosmic:720340, Cosmic:873696, Cosmic:875297, Cosmic:876709, Cosmic:887244, Cosmic:889531, Cosmic:948127, Cosmic:948829, Cosmic:983736, Cosmic:995392, Cosmic:1043805, Cosmic:1122320, Cosmic:1132564, Cosmic:1132694, Cosmic:1184081, Cosmic:1187299, Cosmic:1310931, Cosmic:1466811, Cosmic:1479620, Cosmic:1524334, Cosmic:1552180, Cosmic:1676742, Cosmic:1708415, Cosmic:1803940, Cosmic:1933015, Cosmic:2036652, Cosmic:2145574, Cosmic:2156940, Cosmic:2301543, Cosmic:2301964, Cosmic:2667879, Cosmic:2800568, DepMap:ACH-000003, DSMZ:ACC-169, DSMZCellDive:ACC-169, ECACC:09042001, ECACC:86010202, EGA:EGAS00001000610, EGA:EGAS00001002554, ENCODE:ENCBS311PHE, ENCODE:ENCBS390JMI, ENCODE:ENCBS391ENC, ENCODE:ENCBS530YXL, ENCODE:ENCBS700RKG, ENCODE:ENCBS890JZY, FANTOM5_SSTAR:10513-107D9, FCS-free:192-2-378-1-3-3, GEO:GSM206450, GEO:GSM274711, GEO:GSM274712, GEO:GSM274725, GEO:GSM383861, GEO:GSM472900, GEO:GSM472933, GEO:GSM513908, GEO:GSM514182, GEO:GSM741244, GEO:GSM749689, GEO:GSM749691, GEO:GSM749748, GEO:GSM784006, GEO:GSM843481, GEO:GSM843482, GEO:GSM845394, GEO:GSM945162, GEO:GSM945203, GEO:GSM945206, GEO:GSM945236, GEO:GSM1006210, GEO:GSM1006211, GEO:GSM1006212, GEO:GSM1346866, GEO:GSM1374426, GEO:GSM1448160, GEO:GSM2549989, GEO:GSM7701359, GEO:GSM7701360, IARC_TP53:21749, IBRC:C10094, ICLC:HTL97023, IZSLER:BS TCL 87, KCB:KCB 200710YJ, KCLB:30037.1, LINCS_LDP:LCL-1170, Lonza:36, MeSH:D018938, MetaboLights:MTBLS227, MetaboLights:MTBLS328, NCBI_Iran:C139, PharmacoDB:Caco2_161_2019, PRIDE:PXD001550, PRIDE:PXD005354, PRIDE:PXD005355, PRIDE:PXD018357, PRIDE:PXD019645, PRIDE:PXD023760, Progenetix:CVCL_0025, PubChem_Cell_line:CVCL_0025, RCB:RCB0988, TOKU-E:762, Ubigene:YC-D003, Wikidata:Q5016050 |
|
|
CVCL_0025 |
2026-08-15 04:19:53 |
9197 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
RRID:CVCL_0235
|
|
|
Derived from sampling site: Kidney., Omics: Transcriptome analysis., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: GPI-anchored proteins analysis by proteomics., Omics: Deep RNAseq analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Doubling time: ~30-40 hours (DSMZ)., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:10723130 PMID:10929426 PMID:17409424 PMID:20215515 PMID:22460905 PMID:22949125 PMID:25485619 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
|
|
BTO:BTO:0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140/p524_Caki-2, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, ECACC:93120819, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ATCC Cat# HTB-47, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ATCC |
HTB-47 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
CAL-120
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1104
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:20215515 PMID:22460905 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30613774 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
CAL 120, CAL120 |
|
|
CLO:CLO_0002179, EFO:EFO_0005356, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-6647, BioGRID_ORCS_Cell_line:166, BioSample:SAMN03472991, BioSample:SAMN03473555, BioSample:SAMN10989564, cancercelllines:CVCL_1104, Cell_Model_Passport:SIDM00940, ChEMBL-Cells:CHEMBL3308577, ChEMBL-Targets:CHEMBL1075405, Cosmic:906826, Cosmic:1995355, Cosmic:2164984, Cosmic-CLP:906826, DepMap:ACH-000212, DSMZ:ACC-459, DSMZCellDive:ACC-459, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906826, GEO:GSM274647, GEO:GSM274665, GEO:GSM344361, GEO:GSM344411, GEO:GSM783963, GEO:GSM827160, GEO:GSM843483, GEO:GSM847210, GEO:GSM847455, GEO:GSM886904, GEO:GSM887969, GEO:GSM1172944, GEO:GSM1669645, IARC_TP53:21208, LiGeA:CCLE_802, LINCS_HMS:51110, LINCS_LDP:LCL-1463, PharmacoDB:CAL120_165_2019, PRIDE:PXD030304, Progenetix:CVCL_1104, PubChem_Cell_line:CVCL_1104, SLKBase:3487, Wikidata:Q54808384 |
|
|
CVCL_1104 |
2026-08-15 04:19:56 |
20 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
ICLC Cat# HTL95029, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
ICLC |
HTL95029 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
DSMZ Cat# ACC-54, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
DSMZ |
ACC-54 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:56 |
278 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
BCRJ Cat# 0408, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
BCRJ |
0408 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:59 |
278 |
CAL-12T
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1105
|
Homo sapiens (Human)
|
Lung non-small cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1657424 PMID:2145926 PMID:2440566 PMID:18083107 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29681454 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
Cal-12T, Cal.12T, CAL 12T, CAL12T, Cal12T, CAL 12, Centre Antoine Lacassagne-12T |
|
|
CLO:CLO_0002180, EFO:EFO_0006547, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473097, BioSample:SAMN10987846, cancercelllines:CVCL_1105, Cell_Model_Passport:SIDM00939, ChEMBL-Cells:CHEMBL3308132, ChEMBL-Targets:CHEMBL1075406, Cosmic:753540, Cosmic:1995356, Cosmic-CLP:753540, DepMap:ACH-000826, DSMZ:ACC-443, DSMZCellDive:ACC-443, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:753540, GEO:GSM784241, GEO:GSM827248, GEO:GSM886905, GEO:GSM887970, GEO:GSM1669646, IARC_TP53:21209, LiGeA:CCLE_097, LINCS_LDP:LCL-1603, PharmacoDB:CAL12T_166_2019, PRIDE:PXD030304, Progenetix:CVCL_1105, PubChem_Cell_line:CVCL_1105, Wikidata:Q54808385 |
|
|
CVCL_1105 |
2026-08-15 04:19:56 |
2 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
KCLB Cat# 30047, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
KCLB |
30047 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-08-15 04:19:59 |
278 |
CAL-72
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-439, RRID:CVCL_1113
|
Homo sapiens (Human)
|
Osteosarcoma
|
Karyotypic information: Has lost chromosome Y (PubMed=10389764)., Population: African., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10389764 PMID:11668190 PMID:12631258 PMID:20164919 PMID:27397505 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Male |
CAL 72, CAL72, Cal72, Centre Antoine Lacassagne-72 |
DSMZ |
ACC-439 |
BTO:BTO_0002089, CLO:CLO_0002188, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:842, BioSample:SAMN03473545, cancercelllines:CVCL_1113, Cell_Model_Passport:SIDM00930, ChEMBL-Cells:CHEMBL3308718, ChEMBL-Targets:CHEMBL1075414, Cosmic:906827, Cosmic:1074399, Cosmic-CLP:906827, DepMap:ACH-001715, DSMZ:ACC-439, DSMZCellDive:ACC-439, EGA:EGAS00001000978, GDSC:906827, GEO:GSM320825, GEO:GSM1669655, IARC_TP53:21214, LINCS_LDP:LCL-1419, PharmacoDB:CAL72_175_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1113, Wikidata:Q54808412 |
|
|
CVCL_1113 |
2026-08-15 04:19:59 |
1 |
CAL-54
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-365, RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
DSMZ |
ACC-365 |
CLO:CLO_0002186, EFO:EFO_0002125, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473166, BioSample:SAMN10988487, cancercelllines:CVCL_1111, Cell_Model_Passport:SIDM00932, ChEMBL-Cells:CHEMBL3308346, ChEMBL-Targets:CHEMBL1075412, Cosmic:910952, Cosmic-CLP:910952, DepMap:ACH-000457, DSMZ:ACC-365, DSMZCellDive:ACC-365, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910952, GEO:GSM886910, GEO:GSM887976, GEO:GSM1669653, IARC_TP53:21212, IGRhCellID:CAL54, LiGeA:CCLE_129, LINCS_LDP:LCL-1757, PharmacoDB:CAL54_173_2019, PRIDE:PXD030304, Progenetix:CVCL_1111, PubChem_Cell_line:CVCL_1111, Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-08-15 04:19:56 |
1 |
Calu-6
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0236
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1855224 PMID:2388294 PMID:3129183 PMID:3335022 PMID:3518877 PMID:3940644 PMID:6148444 PMID:6935474 PMID:7459858 PMID:7834619 PMID:7972006 PMID:8385084 PMID:12068308 PMID:12794755 PMID:20164919 PMID:20215515 PMID:20679594 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28273808 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
CaLu-6, CALU-6, Calu.6, Calu 6, Calu6, CALU6, CaLu-06 |
|
|
BTO:BTO_0002235, CLO:CLO_0002193, EFO:EFO_0002152, MCCL:MCC:0000125, CLDB:cl636, CLDB:cl638, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-56, BioGRID_ORCS_Cell_line:587, BioSample:SAMN03473148, BioSample:SAMN10987791, cancercelllines:CVCL_0236, CancerTools:161924, CCRID:1101HUM-PUMC000813, CCRID:3101HUMTCHu144, Cell_Model_Passport:SIDM00921, ChEMBL-Cells:CHEMBL3307639, ChEMBL-Targets:CHEMBL614535, CLS:300135, Cosmic:724859, Cosmic:929969, Cosmic:933575, Cosmic:934466, Cosmic:934542, Cosmic:1071885, Cosmic:1089230, Cosmic:1146874, Cosmic:1176611, Cosmic:1434959, Cosmic:1995360, Cosmic:2668262, Cosmic-CLP:724859, DepMap:ACH-000264, DSMZ:ACC-734, DSMZCellDive:ACC-734, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:724859, GEO:GSM108805, GEO:GSM108806, GEO:GSM253341, GEO:GSM434325, GEO:GSM513938, GEO:GSM514319, GEO:GSM794263, GEO:GSM817065, GEO:GSM843487, GEO:GSM886916, GEO:GSM887982, GEO:GSM1374435, GEO:GSM1374436, GEO:GSM1669659, IARC_TP53:119, IARC_TP53:21265, ICLC:HTL97003, IGRhCellID:Calu6, KCLB:30056, LiGeA:CCLE_215, LINCS_LDP:LCL-1626, Lonza:1139, NCBI_Iran:C431, PharmacoDB:Calu6_180_2019, PRIDE:PXD025499, PRIDE:PXD030304, Progenetix:CVCL_0236, PubChem_Cell_line:CVCL_0236, Wikidata:Q54808427 |
|
|
CVCL_0236 |
2026-08-15 04:19:57 |
35 |
CAL-62
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1112
|
Homo sapiens (Human)
|
Thyroid gland anaplastic carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1369551 PMID:18713817 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23833040 PMID:25365311 PMID:27397505 PMID:30737244 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
Cal-62, CAL 62, Cal 62, CAL62, Centre Antoine Lacassagne-62 |
|
|
BTO:BTO_0002146, CLO:CLO_0002187, EFO:EFO_0002126, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473548, BioSample:SAMN10988563, cancercelllines:CVCL_1112, CCRID:3101HUMSCSP546, Cell_Model_Passport:SIDM00931, ChEMBL-Cells:CHEMBL3308099, ChEMBL-Targets:CHEMBL1075413, CLS:305114, Cosmic:891257, Cosmic:906828, Cosmic:1152118, Cosmic:1162838, Cosmic:1239974, Cosmic:2054116, Cosmic:2613252, Cosmic-CLP:906828, DepMap:ACH-000174, DSMZ:ACC-448, DSMZCellDive:ACC-448, EGA:EGAS00001000978, GDSC:906828, GEO:GSM886911, GEO:GSM887977, GEO:GSM1669654, IARC_TP53:21213, IGRhCellID:CAL62, LiGeA:CCLE_550, LINCS_LDP:LCL-1683, PharmacoDB:CAL62_174_2019, PRIDE:PXD030304, Progenetix:CVCL_1112, PubChem_Cell_line:CVCL_1112, Wikidata:Q54808410 |
|
|
CVCL_1112 |
2026-08-15 04:19:59 |
14 |
CAL-29
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1808
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2440566 PMID:11720483 PMID:20215515 PMID:22460905 PMID:24035680 PMID:24367658 PMID:26589293 PMID:27397505 PMID:29732388 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Female |
CAL 29, CAL29, Centre Antoine Lacassagne-29 |
|
|
CLO:CLO_0037157, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:584, BioSample:SAMN03473515, BioSample:SAMN10988514, cancercelllines:CVCL_1808, Cell_Model_Passport:SIDM00936, Cosmic:1285115, Cosmic:1995357, Cosmic:2050440, Cosmic:2057444, Cosmic:2444248, Cosmic:2685941, Cosmic-CLP:1290730, DepMap:ACH-000142, DSMZ:ACC-515, DSMZCellDive:ACC-515, EGA:EGAS00001000978, GDSC:1290730, GEO:GSM827161, GEO:GSM886908, GEO:GSM887973, GEO:GSM1669649, IARC_TP53:28275, LiGeA:CCLE_765, LINCS_LDP:LCL-1711, PharmacoDB:CAL29_169_2019, PRIDE:PXD030304, Progenetix:CVCL_1808, Wikidata:Q54808396 |
|
|
CVCL_1808 |
2026-08-15 04:19:56 |
4 |
CAL-27
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1107
|
Homo sapiens (Human)
|
Tongue adenosquamous carcinoma
|
Population: Caucasian., Part of: OPC-22 oral and pharyngeal cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2145926 PMID:2440566 PMID:3181269 PMID:19631575 PMID:20014447 PMID:20164919 PMID:21868764 PMID:22460905 PMID:24201445 PMID:25275298 PMID:25485619 PMID:25877200 PMID:25888065 PMID:26589293 PMID:27108184 PMID:27397505 PMID:28196595 PMID:28476783 PMID:29156801 PMID:29770536 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34977030 PMID:35839778 PMID:36912284
|
Cancer cell line
|
Male |
Cal-27, CAL 27, Cal 27, CAL27, Cal27, CAL-SCC-27, Centre Antoine Lacassagne-27 |
|
|
BTO:BTO_0000921, CLO:CLO_0002178, CLO:CLO_0002182, EFO:EFO_0006366, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2095, BCRJ:0326, BioGRID_ORCS_Cell_line:336, BioSample:SAMN03471886, BioSample:SAMN10987905, cancercelllines:CVCL_1107, CCRID:1101HUM-PUMC000338, CCRID:4201HUM-CCTCC00248, CCTCC:GDC0248, Cell_Model_Passport:SIDM00937, ChEMBL-Cells:CHEMBL3308098, ChEMBL-Targets:CHEMBL1075408, CLS:305029, Cosmic:686972, Cosmic:910916, Cosmic:1006469, Cosmic:1017793, Cosmic:1041674, Cosmic:1339913, Cosmic:1466800, Cosmic:1530734, Cosmic:1752762, Cosmic:2043896, Cosmic:2131842, Cosmic:2296292, Cosmic-CLP:910916, DepMap:ACH-000832, DSMZ:ACC-446, DSMZCellDive:ACC-446, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910916, GEO:GSM422868, GEO:GSM423671, GEO:GSM886907, GEO:GSM887972, GEO:GSM1374427, GEO:GSM1374428, GEO:GSM1519074, GEO:GSM1519075, GEO:GSM1519076, GEO:GSM1669648, IARC_TP53:17482, IGRhCellID:CAL27%20GSE9585, LiGeA:CCLE_698, LINCS_LDP:LCL-1215, PharmacoDB:CAL27_168_2019, PRIDE:PXD002132, PRIDE:PXD028810, PRIDE:PXD029420, PRIDE:PXD030304, Progenetix:CVCL_1107, PubChem_Cell_line:CVCL_1107, Wikidata:Q54808394 |
|
|
CVCL_1107 |
2026-08-15 04:19:59 |
368 |
CAL-54
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
|
|
CLO:CLO_0002186, EFO:EFO_0002125, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473166, BioSample:SAMN10988487, cancercelllines:CVCL_1111, Cell_Model_Passport:SIDM00932, ChEMBL-Cells:CHEMBL3308346, ChEMBL-Targets:CHEMBL1075412, Cosmic:910952, Cosmic-CLP:910952, DepMap:ACH-000457, DSMZ:ACC-365, DSMZCellDive:ACC-365, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910952, GEO:GSM886910, GEO:GSM887976, GEO:GSM1669653, IARC_TP53:21212, IGRhCellID:CAL54, LiGeA:CCLE_129, LINCS_LDP:LCL-1757, PharmacoDB:CAL54_173_2019, PRIDE:PXD030304, Progenetix:CVCL_1111, PubChem_Cell_line:CVCL_1111, Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-08-15 04:19:56 |
1 |